ClinicalTrials.Veeva

Menu

Clinical Effect of Individualized Exercise Prescription for Hypertension With 6-minute Walking Test (6MWT)

P

Peking University

Status

Not yet enrolling

Conditions

Hypertension

Treatments

Behavioral: CPET exercise prescription
Behavioral: 6MWT exercise prescription
Behavioral: Regular exercise

Study type

Interventional

Funder types

Other

Identifiers

NCT06219512
RDL2022-23

Details and patient eligibility

About

Obesity and lack of exercise are one of the reasons for high blood pressure. Exercise can reduce the risk of cardiovascular events by reducing weight and blood pressure. The precise formulation of exercise prescription by cardiopulmonary exercise test (CPET) can effectively control hypertension. Our research group has formulated 50 "exercise prescriptions for hypertension population" in the early stage, but how to further effectively implement them needs to be discussed.

Based on the previous experience of undertaking the project "Exercise Prescription for Hypertensive People" of General Administration of Sport of the People's Republic of China, this research group discussed the important role of intelligent information management in the clinical effect evaluation and effective implementation of exercise prescription for hypertension; To explore the feasibility of making exercise prescription for hypertension based on 6-min walking test, and whether it is not inferior to or equivalent to the accuracy and effectiveness of making exercise prescription by CPET. The relevant results will lay a foundation for exploring the broader adaptation of hypertension exercise prescription to the population.

Full description

The 6-minute walking test (6MWT) has good universality and accessibility, and can be used as the basis for formulating exercise prescriptions. According to the consensus of Chinese experts on the application of clinical norms of the six-minute walking test, it is recommended to formulate individualized exercise prescriptions based on the average walking speed of 6MWT calculated from the six-minute walking distance (6MWD), but there is no relevant content about hypertension.

Enrollment

126 estimated patients

Sex

All

Ages

45 to 64 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Overweight/obesity; Normal or normal high blood pressure after drug use; Grade 1 hypertension (whether taking medicine or not); Having sports habits; Sports risk is low and medium

Exclusion criteria

  • ≥ grade 2 Hypertension; High-risk hypertensive patients; Malignant hypertension, secondary hypertension, etc; Serious arrhythmia, heart failure, acute myocardial infarction; Severe stroke, liver and kidney insufficiency; Physical dysfunction and failure to cooperate for various reasons; Unable to conduct CPET; The Types and doses of antihypertensive drugs is still in the process of adjustment

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

126 participants in 3 patient groups

CPET exercise prescription group
Experimental group
Description:
Formulate exercise prescription of cardiopulmonary exercise test (CPET) according to the principle of FITT [frequency, intensity, time and type]
Treatment:
Behavioral: CPET exercise prescription
6MWT exercise prescription group
Experimental group
Description:
Exercise prescription is set according to the recommendation of the Chinese expert consensus on the application of clinical norms of six-minute walking test
Treatment:
Behavioral: 6MWT exercise prescription
Regular exercise group
Active Comparator group
Description:
Carry out regular exercise as usual
Treatment:
Behavioral: Regular exercise

Trial contacts and locations

0

Loading...

Central trial contact

Yang Xi, Doctor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems